Judith A Hahn1,2, Nneka I Emenyonu1, Robin Fatch1, Winnie R Muyindike3, Allen Kekiibina3, Adam W Carrico4, Sarah Woolf-King1, Stephen Shiboski2. 1. University of California, Department of Medicine, San Francisco, CA, USA. 2. University of California, Department of Epidemiology and Biostatistics, San Francisco, CA, USA. 3. Mbarara University of Sciences and Technology, Faculty of Medicine, Mbarara, Uganda. 4. University of California, Department of Community Health Systems, San Francisco, CA, USA.
Abstract
AIMS: We examined whether unhealthy alcohol consumption, which negatively impacts HIV outcomes, changes after HIV care entry overall and by several factors. We also compared using phosphatidylethanol (PEth, an alcohol biomarker) to augment self-report to using self-report alone. DESIGN: A prospective 1-year observational cohort study with quarterly visits. SETTING: Large rural HIV clinic in Mbarara, Uganda. PARTICIPANTS: A total of 208 adults (89 women and 119 men) entering HIV care, reporting any prior year alcohol consumption. MEASUREMENTS: Unhealthy drinking was PEth+ (≥ 50 ng/ml) or Alcohol Use Disorders Identification Test-Consumption+ (AUDIT-C+, over 3 months, women ≥ 3; men ≥ 4). We calculated adjusted odds ratios (AOR) for unhealthy drinking per month since baseline, and interactions of month since baseline with perceived health, number of HIV symptoms, antiretroviral therapy (ART), gender and self-reported prior unhealthy alcohol use. FINDINGS: The majority of participants (64%) were unhealthy drinkers (PEth+ or AUDIT-C+) at baseline. There was no significant trend in unhealthy drinking overall [per-month AOR: 1.01; 95% confidence interval (CI) = 0.94-1.07], while the per-month AORs were 0.91 (95% CI = 0.83-1.00) and 1.11 (95% CI = 1.01-1.22) when participants were not yet on ART and on ART, respectively (interaction P-value < 0.01). In contrast, 44% were AUDIT-C+; the per-month AORs for being AUDIT-C+ were 0.89 (95% CI = 0.85-0.95) overall, and 0.84 (95% CI = 0.78-0.91) and 0.97 (95% CI = 0.89-1.05) when participants were not on and were on ART, respectively. CONCLUSIONS: Unhealthy alcohol use among Ugandan adults entering HIV care declines prior to the start of anti-retroviral therapy but rebounds with time. Augmenting self-reported alcohol use with biomarkers increases the ability of current alcohol use measurements to detect unhealthy alcohol use.
AIMS: We examined whether unhealthy alcohol consumption, which negatively impacts HIV outcomes, changes after HIV care entry overall and by several factors. We also compared using phosphatidylethanol (PEth, an alcohol biomarker) to augment self-report to using self-report alone. DESIGN: A prospective 1-year observational cohort study with quarterly visits. SETTING: Large rural HIV clinic in Mbarara, Uganda. PARTICIPANTS: A total of 208 adults (89 women and 119 men) entering HIV care, reporting any prior year alcohol consumption. MEASUREMENTS: Unhealthy drinking was PEth+ (≥ 50 ng/ml) or Alcohol Use Disorders Identification Test-Consumption+ (AUDIT-C+, over 3 months, women ≥ 3; men ≥ 4). We calculated adjusted odds ratios (AOR) for unhealthy drinking per month since baseline, and interactions of month since baseline with perceived health, number of HIV symptoms, antiretroviral therapy (ART), gender and self-reported prior unhealthy alcohol use. FINDINGS: The majority of participants (64%) were unhealthy drinkers (PEth+ or AUDIT-C+) at baseline. There was no significant trend in unhealthy drinking overall [per-month AOR: 1.01; 95% confidence interval (CI) = 0.94-1.07], while the per-month AORs were 0.91 (95% CI = 0.83-1.00) and 1.11 (95% CI = 1.01-1.22) when participants were not yet on ART and on ART, respectively (interaction P-value < 0.01). In contrast, 44% were AUDIT-C+; the per-month AORs for being AUDIT-C+ were 0.89 (95% CI = 0.85-0.95) overall, and 0.84 (95% CI = 0.78-0.91) and 0.97 (95% CI = 0.89-1.05) when participants were not on and were on ART, respectively. CONCLUSIONS: Unhealthy alcohol use among Ugandan adults entering HIV care declines prior to the start of anti-retroviral therapy but rebounds with time. Augmenting self-reported alcohol use with biomarkers increases the ability of current alcohol use measurements to detect unhealthy alcohol use.
Authors: Jeanne M Marrazzo; Gita Ramjee; Barbra A Richardson; Kailazarid Gomez; Nyaradzo Mgodi; Gonasagrie Nair; Thesla Palanee; Clemensia Nakabiito; Ariane van der Straten; Lisa Noguchi; Craig W Hendrix; James Y Dai; Shayhana Ganesh; Baningi Mkhize; Marthinette Taljaard; Urvi M Parikh; Jeanna Piper; Benoît Mâsse; Cynthia Grossman; James Rooney; Jill L Schwartz; Heather Watts; Mark A Marzinke; Sharon L Hillier; Ian M McGowan; Z Mike Chirenje Journal: N Engl J Med Date: 2015-02-05 Impact factor: 91.245
Authors: Rebecca K Papas; Benson N Gakinya; Joyce B Baliddawa; Steve Martino; Kendall J Bryant; Eric M Meslin; John E Sidle Journal: J Empir Res Hum Res Ethics Date: 2012-07 Impact factor: 1.742
Authors: Francis Bajunirwe; Jessica E Haberer; Yap Boum; Peter Hunt; Rain Mocello; Jeffrey N Martin; David R Bangsberg; Judith A Hahn Journal: PLoS One Date: 2014-12-01 Impact factor: 3.240
Authors: Radhika Sundararajan; Monique A Wyatt; Sarah Woolf-King; Emily E Pisarski; Nneka Emenyonu; Winnie R Muyindike; Judith A Hahn; Norma C Ware Journal: AIDS Behav Date: 2015-04
Authors: Annet Kembabazi; Francis Bajunirwe; Peter W Hunt; Jeffrey N Martin; Conrad Muzoora; Jessica E Haberer; David R Bangsberg; Mark J Siedner Journal: PLoS One Date: 2013-07-19 Impact factor: 3.240
Authors: Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook Journal: Alcohol Clin Exp Res Date: 2017-12-05 Impact factor: 3.455
Authors: Nneka I Emenyonu; Robin Fatch; Winnie R Muyindike; Allen Kekibiina; Sarah Woolf-King; Judith A Hahn Journal: J Stud Alcohol Drugs Date: 2017-03 Impact factor: 2.582
Authors: Risha Irvin; Geetanjali Chander; Kathleen M Ward; Sean Manogue; Oluwaseun Falade-Nwulia; Juhi Moon; Catherine G Sutcliffe; Sherilyn Brinkley; Taryn Haselhuhn; Stephanie Katz; Kayla Herne; Lilian Arteaga; David L Thomas; Shruti H Mehta; Mark S Sulkowski Journal: J Viral Hepat Date: 2020-01-07 Impact factor: 3.728
Authors: Gregory J Patts; Debbie M Cheng; Nneka Emenyonu; Carly Bridden; Natalia Gnatienko; Christine A Lloyd-Travaglini; Christine Ngabirano; Tatiana Yaroslavtseva; Winnie R Muyindike; Sheri D Weiser; Evgeny M Krupitsky; Judith A Hahn; Jeffrey H Samet Journal: AIDS Behav Date: 2017-03
Authors: Oghenowede Eyawo; Kathleen A McGinnis; Amy C Justice; David A Fiellin; Judith A Hahn; Emily C Williams; Adam J Gordon; Brandon D L Marshall; Kevin L Kraemer; Stephen Crystal; Julie R Gaither; E Jennifer Edelman; Kendall J Bryant; Janet P Tate Journal: J Acquir Immune Defic Syndr Date: 2018-02-01 Impact factor: 3.731
Authors: Stephen B Asiimwe; Robin Fatch; Gregory Patts; Michael Winter; Christine Lloyd-Travaglini; Nneka Emenyonu; Winnie Muyindike; Allen Kekibiina; Elena Blokhina; Natalia Gnatienko; Evgeny Kruptisky; Debbie M Cheng; Jeffrey H Samet; Judith A Hahn Journal: AIDS Behav Date: 2017-11